Business
ChromaDex’s Tru Niagen® Won the "Most Popular Brand of the Year Award" at China International Natural Health & Nutrition Expo’s (NHNE) Prestigious Nutrition Planet Awards
Tru Niagen® was recognized for its industry-leading research, increased presence on cross-border e-commerce channels, and high engagement on several social
About this update from Niagen Bioscience, Inc.
[{"type":"text","content":"\nTru Niagen® was recognized for its industry-leading research, increased presence on cross-border e-commerce channels, and high engagement on several social media platforms in Mainland China\n\n LOS ANGELES--(BUSINESS WIRE)--\nChromaDex Corp. (NASDAQ:CDXC), a global bioscience company dedicated to healthy aging, announced that its consumer nicotinamide adenine dinucleotide (NAD+) boosting supplement, Tru Niagen®, won the “Most Popular Brand of the Year Award” at Asia’s largest trade show on natural health and nutrition products, China International Natural Health & Nutrition Expo (NHNE), during the prestigious Nutrition Planet Awards on September 20, 2022 in Shanghai. With over 100,000 distributors and retailers, NHNE is considered the best platform to help global manufacturers of health food and nutrition products to promote their brands and expand business channels in China, where Tru Niagen® is currently sold cross-border.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221024005152/en/Sinopharm Xingsha celebrates the launch of Tru Niagen at NHNE (Photo: Business Wire)\nNiagen®, the proprietary ingredient in Tru Niagen®, is the world’s most efficient, patent protected NAD+ precursor on the market, particularly over NMN, and is one of the most promising ingredients to have entered the healthy aging supplement space. Supplementation with Niagen® is backed by 20 published and peer-reviewed clinical trials, over 200 published scientific studies and over 30 owned and licensed patents. ChromaDex continues to lead the industry in NAD+ research, with the ChromaDex External Research Program (CERPTM) achieving over 250 material transfer agreements (MTAs) featuring Niagen® and other proprietary ingredients.\n\n“On behalf of ChromaDex, we are deeply honored that Tru Niagen® received this award and thank Sinopharm Xingsha for helping to make it possible,” said Rob Fried, CEO of ChromaDex. “As a research-driven company with science at our core, this recognition reinforces our intention to become the leading provider of NAD+ boosting supplements in China and we look forward to executing the next phase of growth with Sinopharm Xingsha.”\n\nAs a large-scale professional exhibition of health nutrition and health care products in Asia, NHNE provides excellent brand promotion and pro...